| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Kezar Life Sciences, Inc.
13D/A
KZR · 49372L100
|
8.7% |
3/3/2025
Event 2/28/2025
|
||||
| Equal Talent Investments Limited | 8.7% | |||||
| Tracy Gia Yunn Tsoi | 8.7% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.